Skip to main content
Premium Trial:

Request an Annual Quote

Centogene: Philip Lambert, Peter Bauer

Philip Lambert has become CSO of Centogene, replacing Peter Bauer, who is now the firm's chief genomic officer. Lambert joins the company from Life Biosciences, where he was senior VP of discovery and labs as well as chief operating officer of two subsidiaries, Selphagy Therapeutics and Spotlight Biosciences. Prior to that, he was scientific partner and head of discovery at Charles River Laboratories. He also cofounded preclinical screening firm VivoPath. Lambert holds a PhD in neuropharmacology from Imperial College London and a BSc in pharmacology from the University of Liverpool.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.